Fibromyalgia syndrome
Conditions
Interventions
treat group :Shugan Dingtong decoction
control group :Duloxetine Hydrochloride
Sponsors
China-Japan Friendship Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged 18–70 years; 2. Patients who meet the diagnostic criteria of American College of Rheumatology in 2016; 3. Patients who meet the diagnostic criteria of Syndrome of stagnation of liver qi; 4. Pain scores 3-7 on visual analogue scale (VAS); 5. Patients sign the informed consent forms.
Exclusion criteria
Exclusion criteria: 1. Pregnant and lactating women; 2. Patients with serious primary diseases of respiratory, digestive, urinary, cardiovascular and immune system; 3. Patients with mental and psychological disorders including cognitive impairment, severe depression, somatoform disorders; 4. Patients with secondary FM resulted from osteoarthritis, rheumatoid arthritis, trauma, hypothyroidism, malignant tumor; 5. Patients with severe pain resulted from diabetic and postherpetic neuralgia; 6. Patients who are allergic to the drugs used in this study; 7. Patients are participation in any other clinical trials or receive other drugs for the treatment of FM; 8. Patients with implanted metal in the body or a history of claustrophobia and panic attacks that prevent fMRI examinations.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analog pain score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Fibromyalgia Quality of Life Score;FS-14 Fatigue Score;Sleep quality PSQI score;TCM Syndrome Score; | — |
Countries
China
Contacts
Public ContactXu Yuan
China-Japan Friendship Hospital
Outcome results
None listed